While using compounded instead of FDA-approved medications can work for patients, safety and efficacy problems can also arise
Importantly, physical performance outcomes such as mobility and functional capacity are generally maintained, indicating that moderate lean mass loss during therapy does not necessarily equate to clinically relevant impairment [19, 26]
Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria
10.1038/s41598-017-19055-6 147 PozoL.BelloF.SuarezA.Ochoa-MartinezF
MC1R agonists have been investigated for photosensitivity conditions (this is a specialist indication requiring dermatologist involvement) Sexual desire and arousal: MC3R/MC4R-mediated central effects on libido and arousal in both men and women (the same mechanism as PT-141, the FDA-approved derivative) Appetite regulation and weight management: MC4R-mediated appetite suppression as one component of a physician-supervised metabolic program Erectile dysfunction with low desire component: central melanocortin pathway activation as an alternative or complement to PDE5 inhibitors Melanotan-2 has a broader receptor activity profile than its derivative PT-141 (bremelanotide), which was specifically developed to retain the sexual function effects (MC3R/MC4R) while eliminating the tanning effect (MC1R)
Brain imaging has provided key informations on PAIS-associated neuroinflammation, on long COVID-associated hypometabolism, and even on COVID-induced changes in brain structures